INVENTIVA (EPA:IVA) Inventiva announces participation at several investors conferences in May and June 2022
Directive transparence : information réglementée
Inventiva secures a new patent expanding the IP protection of its lead...
Inventiva announces a new Director of the Board of Directors
Inventiva reports 2022 Third Quarter Financial Information¹
Inventiva provides an update on the development of cedirogant by AbbVie
Inventiva announces a scientific presentation at the AASLD The Liver...
Inventiva and Sino Biopharm announce licensing and collaboration agreement...
Inventiva announces the schedule of publication and presentation of its...
Inventiva Reports 2022 First-Half Financial Information¹
Inventiva announces the screening of the first patient in LEGEND, a Phase...
Inventiva to host a webcast with Key Opinion Leaders following the EASL...
Voir tous les communiqués de INVENTIVA
©Dissemination technology Webdisclosure.com - copyright 2022 SYMEX ECONOMICS all rights reserved